Show results for
Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Antigen Bound Equipment Supplied In Usa
4 equipment items found
Manufactured by:DRG International, Inc. based inSpringfield, NEW JERSEY (USA)
AMA-M2 ELISA is an test system for the quantitative measurement of IgG class autoantibodies against mitochondrial M2 subtype antigen in human serum or plasma. Highly purified mitochondrial M2 subtype antigen is bound to microwells. Antibodies against the coated antigen, if present in diluted patient sample, bind to the respective ...
Manufactured by:IVD Research, Inc. based inCarlsbad, CALIFORNIA (USA)
Caused by the Campylobacter bacteria, campylobacteriosis is the most common human form of gastroenteritis in the world. Humans generally contract campylobacteriosis by consuming contaminated animal products. While the disease is generally not dangerous, it can be life-threatening for the elderly and young infants, as well as for people with compromised immune systems. It has also been associated ...
Manufactured by:IVD Research, Inc. based inCarlsbad, CALIFORNIA (USA)
Giardiasis, caused by the single-celled Giardia lambliaparasite, is the most common parasitic disease in the United States. As many as 100 million mild infections and 1 million severe infections are reported ...
by:Metaclipse Therapeutics Corporation based inAtlanta, GEORGIA (US) (USA)
Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane vesicles’ prepared from a patient’s tumor tissue that Metaclipse modifies with a ‘protein transfer’ method using proven immunostimulatory proteins. ...